Access cutting-edge acute respiratory distress syndrome treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access acute respiratory distress syndrome specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute respiratory distress syndrome treatment provided free
BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.
Sponsor: BioAegis Therapeutics Inc.
Check if you qualify for this acute respiratory distress syndrome clinical trial in Irvine, CA
If you're searching for acute respiratory distress syndrome treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute respiratory distress syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.